Up-regulation of MiR-340-5p Promotes Progression of Thyroid Cancer by Inhibiting BMP4

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2018 Feb 15

PMID 29441462

Citations 15

Authors

P Zhao

W Ma

Z Hu

Y Zhang

S Zhang

Y Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: The incidence of thyroid cancer is increasing and the proliferation of thyroid cancer cells is incompletely understood. microRNAs may play key roles in thyroid cancer progression.

Methods: We analyzed miR-340-5p in thyroid cancer tissue and normal tissue, and using informatics to predict its target. Cell lines and a mouse model were used to study the role of miR-340-5p in cancer proliferation.

Results: Overexpression of miR-340-5p was found in thyroid cancer specimens. Tumors with higher pathological grade had higher levels of miR-340-5p. Overexpression of miR-340-5p significantly enhanced cell viability and colony formation. Treatment of anti-miR-340-5p, however, showed opposite alterations. We predicted that bone morphogenetic protein 4 (BMP4) is a possible target, and found a negative correlation between miR-340-5p and BMP4 levels in thyroid cancer tissue. miR-340-5p reduced BMP4 expression. BMP4 overexpression attenuated the effects of miR-340-5p in cell viability and colony formation. In addition, using a xenograft mouse model we proved that anti-miR-340-5p was able to inhibit tumor growth.

Conclusions: miR-340-5p promotes thyroid cancer proliferation by inhibiting BMP4. Anti-miR-340-5p can be a promising strategy to control thyroid cancer.

Citing Articles

Spirina L, Kovaleva I, Chizhevskaya S, Chebodaeva A, Tarasenko N Genes (Basel). 2023; 14(3).

PMID: 36980957 PMC: 10048312. DOI: 10.3390/genes14030685.

The role of miR-139-5p in radioiodine-resistant thyroid cancer.

Pecce V, Sponziello M, Verrienti A, Grani G, Abballe L, Bini S J Endocrinol Invest. 2023; 46(10):2079-2093.

PMID: 36933170 PMC: 10514163. DOI: 10.1007/s40618-023-02059-7.

Suppression of microRNA 124-3p and microRNA 340-5p ameliorates retinoic acid-induced cleft palate in mice.

Yoshioka H, Suzuki A, Iwaya C, Iwata J Development. 2022; 149(9).

PMID: 35420127 PMC: 9148563. DOI: 10.1242/dev.200476.

Targeting FHL2-E-cadherin axis by miR-340-5p attenuates colon cancer cell migration and invasion.

Algaber A, Madhi R, Hawez A, Ronnow C, Rahman M Oncol Lett. 2021; 22(2):637.

PMID: 34295384 PMC: 8273858. DOI: 10.3892/ol.2021.12898.

miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1.

Li K, Han F, Wu Y, Wang X Onco Targets Ther. 2021; 14:3635-3648.

PMID: 34113129 PMC: 8187089. DOI: 10.2147/OTT.S302800.

References

Shirai Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K . Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. Am J Pathol. 2011; 179(6):2920-30. PMC: 3260801. DOI: 10.1016/j.ajpath.2011.08.022. View

Reddy K . MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015; 15:38. PMC: 4424445. DOI: 10.1186/s12935-015-0185-1. View

Duerr E, Mizukami Y, Moriichi K, Gala M, Jo W, Kikuchi H . Oncogenic KRAS regulates BMP4 expression in colon cancer cell lines. Am J Physiol Gastrointest Liver Physiol. 2012; 302(10):G1223-30. PMC: 3362092. DOI: 10.1152/ajpgi.00047.2011. View

Zhou Y, Tong L, Chu X, Deng F, Tang J, Tang Y . The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma. Cell Physiol Biochem. 2017; 43(2):733-742. DOI: 10.1159/000481557. View

Zhu J, Wang F, Wang H, Dong N, Zhu X, Wu Y . TNF-α mRNA is negatively regulated by microRNA-181a-5p in maturation of dendritic cells induced by high mobility group box-1 protein. Sci Rep. 2017; 7(1):12239. PMC: 5612954. DOI: 10.1038/s41598-017-12492-3. View

Czajka A, Wojcicka A, Kubiak A, Kotlarek M, Bakula-Zalewska E, Koperski L . Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma. PLoS One. 2016; 11(3):e0151968. PMC: 4807079. DOI: 10.1371/journal.pone.0151968. View

Rupaimoole R, Slack F . MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017; 16(3):203-222. DOI: 10.1038/nrd.2016.246. View

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

Meng X, Zhu P, Li N, Hu J, Wang S, Pang S . Expression of BMP-4 in papillary thyroid carcinoma and its correlation with tumor invasion and progression. Pathol Res Pract. 2017; 213(4):359-363. DOI: 10.1016/j.prp.2017.01.008. View

10.

Song L, Duan P, Gan Y, Li P, Zhao C, Xu J . MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma. Braz J Med Biol Res. 2017; 50(5):e6359. PMC: 5441287. DOI: 10.1590/1414-431X20176359. View

11.

Gao H, Teng C, Huang W, Peng J, Wang C . SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling. Int J Mol Sci. 2015; 16(9):21643-57. PMC: 4613272. DOI: 10.3390/ijms160921643. View

12.

Blenkiron C, Miska E . miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet. 2007; 16 Spec No 1:R106-13. DOI: 10.1093/hmg/ddm056. View

13.

Bai X, Zhang Q, Ye L, Liang F, Sun X, Chen Y . Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling. Oncogene. 2014; 34(31):4089-97. DOI: 10.1038/onc.2014.337. View

14.

Wozniak M, Sztiller-Sikorska M, Czyz M . Diminution of miR-340-5p levels is responsible for increased expression of ABCB5 in melanoma cells under oxygen-deprived conditions. Exp Mol Pathol. 2015; 99(3):707-16. DOI: 10.1016/j.yexmp.2015.11.014. View

15.

Mitra A, Mishra L, Li S . EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 2015; 6(13):10697-711. PMC: 4484413. DOI: 10.18632/oncotarget.4037. View

16.

Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K . ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS One. 2016; 11(1):e0147344. PMC: 4720447. DOI: 10.1371/journal.pone.0147344. View

17.

Fagin J, Wells Jr S . Biologic and Clinical Perspectives on Thyroid Cancer. N Engl J Med. 2016; 375(11):1054-67. PMC: 5512163. DOI: 10.1056/NEJMra1501993. View

18.

Lai E . Two decades of miRNA biology: lessons and challenges. RNA. 2015; 21(4):675-7. PMC: 4371328. DOI: 10.1261/rna.051193.115. View

19.

Lopez J, Wang-Rodriguez J, Chang C, Chen J, Pardo F, Aguilera J . Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines. Arch Otolaryngol Head Neck Surg. 2007; 133(10):1022-7. DOI: 10.1001/archotol.133.10.1022. View

20.

Zhang Q, Lou Y, Zhang J, Fu Q, Wei T, Sun X . Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer. Mol Cancer. 2017; 16(1):119. PMC: 5512744. DOI: 10.1186/s12943-017-0689-5. View